[ RECIPIENT ENTITY RECORD ]

Karuna Therapeutics Inc.

VERIFIED NODE ID: 002035 · karuna-therapeutics-inc
R TARGET NODE — CAPITAL RECIPIENT
Karuna Therapeutics Inc.
Company United States
Recipient Type
Company
Primary Jurisdiction
United States
Registration Status
ACTIVE
Entity Intelligence [ R ]
Legal Name Karuna Therapeutics Inc.
Entity Type Company
Jurisdiction United States
Recipient Intelligence Summary

Karuna Therapeutics is a biopharmaceutical company dedicated to developing transformative medicines for people living with psychiatric and neurological conditions like schizophrenia. Based in Massachusetts, the firm focuses on novel therapies for the brain. It was a significant recipient of institutional healthcare capital through a strategic takeover.

Capital Influx Log (Transactions)
Date Type Amount
23 May 2026 EQUITY $14.0B